Anti‐VEGF administration is currently used to control neovascular processes in both DR and wet AMD.37 Similarly, anti‐VEGF therapies are also helpful against different forms of cancer, such as glioblastoma and colorectal cancer.55 In agreement with this, miR‐205‐5p suppresses VEGFA expression in glioblastoma 7 and also inhibits the PI3K/AKT pathway.13 In accordance with this, reducing VEGF‐angiogenesis and PI3K/AKT could decrease tumour cell viability and proliferation. The gene discussed is AKT1; the disease is wet macular degeneration.